Chemocentryx (CCXI) Holder Bvf Has Cut Holding as Share Price Rose; D-E Shaw & Company Holding in Petroleo Brasileiro Sa Petro (Call) (PBR) Lowered as Stock Value Declined

Petróleo Brasileiro S.A. - Petrobras (NYSE:PBR) Logo

D-E Shaw & Company Inc decreased its stake in Petroleo Brasileiro Sa Petro (Call) (PBR) by 15.54% based on its latest 2019Q1 regulatory filing with the SEC. D-E Shaw & Company Inc sold 434,000 shares as the company’s stock declined 12.92% while stock markets rallied. The hedge fund held 2.36 million shares of the oil & gas production company at the end of 2019Q1, valued at $37.55 million, down from 2.79 million at the end of the previous reported quarter. D-E Shaw & Company Inc who had been investing in Petroleo Brasileiro Sa Petro (Call) for a number of months, seems to be less bullish one the $93.60 billion market cap company. The stock increased 1.76% or $0.26 during the last trading session, reaching $15.03. About 8.70M shares traded. Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) has declined 14.11% since June 5, 2018 and is downtrending. It has underperformed by 18.54% the S&P500. Some Historical PBR News: 25/04/2018 – PETROBRAS REOPENS SALE PROCESS FOR BRAZIL LPG DISTRIBUTOR LIQUIGAS DISTRIBUIDORA, SCRAPPING PLANNED IPO; 03/05/2018 – BRAZIL’S PETROBRAS CHOSES FRANCE’S ENGIE TO ENTER EXCLUSIVE TALKS FOR GAS PIPELINE UNIT TAG; 15/03/2018 – Petrobras Announces Commencement Of Cash Tender Offers; 07/03/2018 – PETROBRAS SAYS EXPORT NOTE SIGNED W/BANCO DO BRASIL ON FEB. 26; 23/05/2018 – Petrobras slashes diesel prices to ease Brazil trucker protest; 29/03/2018 – PETROBRAS AND SHELL WIN ANOTHER BLOCK IN POTIGUAR BASIN IN BRAZIL OIL AUCTION; 30/05/2018 – BRAZIL’S PETROBRAS RAISES GASOLINE PRICES 0.7 PCT STARTING THURSDAY – STATEMENT; 05/03/2018 – Petrobras CEO: Wants Intl Firms in Deepwater Brazil — CERAWeek Market Talk; 25/05/2018 – Brazil authorizes army to clear trucker protest; 23/05/2018 – PETROBRAS SAYS OBJECTIVE OF DIESEL PRICE CUT IS TO GIVE THE GOVERNMENT AND TRUCKERS TIME TO NEGOTIATE

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 78.1% based on its latest 2019Q1 regulatory filing with the SEC. Bvf Inc sold 5.22 million shares as the company’s stock rose 15.42% with the market. The hedge fund held 1.46 million shares of the health care company at the end of 2019Q1, valued at $20.34 million, down from 6.69 million at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $643.17 million market cap company. The stock decreased 1.07% or $0.12 during the last trading session, reaching $11.08. About 244,365 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 11.16% since June 5, 2018 and is uptrending. It has outperformed by 6.73% the S&P500. Some Historical CCXI News: 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA

D-E Shaw & Company Inc, which manages about $81.36B and $77.39B US Long portfolio, upped its stake in Arcelormittal Sa Luxembourg (Call) by 181,400 shares to 200,400 shares, valued at $4.08M in 2019Q1, according to the filing. It also increased its holding in Middleby Corp (NASDAQ:MIDD) by 201,912 shares in the quarter, for a total of 368,812 shares, and has risen its stake in Td Ameritrade Hldg Corp (NYSE:AMTD).

More notable recent Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) news were published by: Seekingalpha.com which released: “My Visit With Petrobras’s IR Team – Seeking Alpha” on February 05, 2019, also Seekingalpha.com with their article: “Petrobras nixes diesel price hike, sending shares down 7% – Seeking Alpha” published on April 12, 2019, Fool.com published: “Why Petrobras Stock Popped 10% – Motley Fool” on January 02, 2019. More interesting news about Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) were released by: Seekingalpha.com and their article: “3 Growth Factors For Petrobras – Seeking Alpha” published on January 11, 2019 as well as Seekingalpha.com‘s news article titled: “Petrobras nears sale of two Brazil offshore oilfields – Reuters – Seeking Alpha” with publication date: May 28, 2019.

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 8. They expect $-0.26 earnings per share, down 85.71% or $0.12 from last year’s $-0.14 per share. After $-0.23 actual earnings per share reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 13.04% negative EPS growth.

Since January 7, 2019, it had 0 insider purchases, and 5 insider sales for $1.38 million activity. The insider Cappel Markus J. sold $74,079. Another trade for 37,893 shares valued at $457,747 was sold by KANAYA SUSAN M.

Bvf Inc, which manages about $999.89 million and $893.07M US Long portfolio, upped its stake in Merus N V by 25,000 shares to 4.54 million shares, valued at $67.06 million in 2019Q1, according to the filing. It also increased its holding in Realm Therapeutics Plc by 252,023 shares in the quarter, for a total of 612,889 shares, and has risen its stake in Five Prime Therapeutics Inc (NASDAQ:FPRX).

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “After-Hours Earnings Report for March 11, 2019 : ADT, COUP, SFIX, DRNA, AVD, PETQ, CCXI, LXFR, MG, OXFD, FRTA, KALA – Nasdaq” on March 11, 2019, also Globenewswire.com with their article: “ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights – GlobeNewswire” published on November 08, 2018, Nasdaq.com published: “ChemoCentryx (CCXI) Moves to Buy: Rationale Behind the Upgrade – Nasdaq” on May 20, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” published on March 28, 2019 as well as Nasdaq.com‘s news article titled: “Takeover of little-known Baoshang casts doubt over other small Chinese banks – Nasdaq” with publication date: May 30, 2019.

Investors sentiment increased to 1.44 in 2019 Q1. Its up 0.51, from 0.93 in 2018Q4. It increased, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. 23,876 are held by Art Advisors Limited Liability Corporation. Bnp Paribas Arbitrage Sa owns 4,696 shares or 0% of their US portfolio. Tiaa Cref Investment Ltd Liability Corporation has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). Wells Fargo And Mn stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Citadel Advisors Ltd reported 26,133 shares. Farallon Mgmt Llc reported 1.50M shares. Dorsey Wright & Assocs has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Employees Retirement System Of Ohio invested 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Bancorp Of Montreal Can holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 123,643 shares. Blackrock, a New York-based fund reported 2.65M shares. Panagora Asset Inc holds 0.02% or 308,857 shares. Barclays Pcl has 13,114 shares. Acadian Asset Mgmt Ltd Liability Com owns 775,123 shares for 0.05% of their portfolio. 1.19 million were accumulated by Dimensional Fund Advisors Ltd Partnership. Metropolitan Life Ins Co owns 42,380 shares.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *